Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02164370 · ClinicalTrials.gov registry record
Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach
A clinical trial of Mild Pre-eclampsia and Severe Pre-eclampsia, sponsored by University of Washington.
- Completed
- Registry status
- 120
- Enrollment target
- 2
- Study locations
NCT02164370: Completed study of Mild Pre-eclampsia and Severe Pre-eclampsia, sponsored by University of Washington.
NCT02164370 is a study of Mild Pre-eclampsia and Severe Pre-eclampsia that has completed, run by University of Washington. The registered enrollment target is 120 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02164370, a study of Mild Pre-eclampsia and Severe Pre-eclampsia, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
Acid/base imbalances are not well understood in pre-eclamptics, and better tools are needed to allow a thorough and meaningful evaluation. Disorders of electrolytes and albumin are common findings \[13, 14\], and the impact of such disorders on acid-base homeostasis has increasingly been acknowledged \[4, 15\]. The purpose of this prospective case-control study is to evaluate acid-base status in 100 women with mild or severe pre-eclampsia and 25 healthy controls by applying the Stewart Fencl's physicochemical acid-base model. We hypothesize that several simultaneous, and possibly offsetting, metabolic acid-base disorders will be identified and quantified, and that these may be useful to guide clinicians in their medical management and indication for delivery. Intermediate and long-term goals are to evaluate the ability of the Stewart Fencl's physicochemical acid-base model to guide fluid management and predict maternal and neonatal outcomes.
Primary Outcome
Primary outcome measure is evaluation of strong ion difference (SID) in mild and severe pre-eclamptic women
Conditions Studied
Study Locations (2)
Washington
- University of Washington - Seattle
Western Cape
- University of Cape Town - Cape Town
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-10 |
What the finished NCT02164370 record still lists
NCT02164370 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Mild Pre-eclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT02164370 reports a single indexed study location in Washington, Western Cape.
Frequently Asked Questions
What is clinical trial NCT02164370 about?
NCT02164370 is a clinical study titled "Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach". Acid/base imbalances are not well understood in pre-eclamptics, and better tools are needed to allow a thorough and meaningful evaluation. Disorders of electrolytes and albumin are common findings \[13, 14\], and the impact of such disorders on acid-base homeostasis has increasingly been acknowledge...
What is the current status of trial NCT02164370?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-10. Estimated completion is 2014-10.
What conditions does trial NCT02164370 study?
This clinical trial studies the following conditions: Mild Pre-eclampsia, Severe Pre-eclampsia.
Who is sponsoring clinical trial NCT02164370?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02164370 being conducted?
This trial has 2 study locations across Washington, Western Cape. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia